Real‐life experience of anifrolumab for cutaneous lupus erythematous.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 7, p. e576, doi. 10.1111/jdv.19755
- By:
- Publication type:
- Article
Works matching AU Viedma‐Martínez, Myriam
Results: 6
1
2
Congenital ichthyosiform erythroderma due to a CYP4F22 mutation responds to ustekinumab: A case report and review of the literature.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 3, p. e389, doi. 10.1111/jdv.18605
- By:
- Publication type:
- Article
3
Anifrolumab use in refractory dermatomyositis: a case report and literature review.
- Published in:
- Clinical & Experimental Dermatology, 2025, v. 50, n. 4, p. 874, doi. 10.1093/ced/llae476
- By:
- Publication type:
- Article
4
Intravenous low-dose cyclophosphamide pulses followed by rituximab for ocular mucous membrane pemphigoid.
- Published in:
- Clinical & Experimental Dermatology, 2025, v. 50, n. 1, p. 169, doi. 10.1093/ced/llae316
- By:
- Publication type:
- Article
5
Hautnekrosen nach COVID‐19‐Impfstoffen.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2022, v. 20, n. 12, p. 1654, doi. 10.1111/ddg.14920_g
- By:
- Publication type:
- Article
6
Skin necrosis after COVID‐19 vaccines.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2022, v. 20, n. 12, p. 1654, doi. 10.1111/ddg.14920
- By:
- Publication type:
- Article